Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker KIDS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 302,369 | $21.01 | $6.4M Sale | Form 4 ↗ |
| Sep 10, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 302,369 | $21.01 | $6.4M Sale | Form 4 ↗ |
| Sep 10, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 302,369 | $21.01 | $6.4M Sale | Form 4 ↗ |
| Sep 2, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 22,500 | $23.35 | $525.4K Sale | Form 4 ↗ |
| Sep 2, 2026 | Squadron Capital LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 22,500 | $23.35 | $525.4K Sale | Form 4 ↗ |
| Sep 2, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 22,500 | $23.35 | $525.4K Sale | Form 4 ↗ |
| Sep 1, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 10,131 | $23.10 | $234.0K Sale | Form 4 ↗ |
| Sep 1, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 10,131 | $23.10 | $234.0K Sale | Form 4 ↗ |
| Sep 1, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 10,131 | $23.10 | $234.0K Sale | Form 4 ↗ |
| Aug 28, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 326,700 | $23.04 | $7.5M Sale | Form 4 ↗ |
| Aug 28, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 326,700 | $23.04 | $7.5M Sale | Form 4 ↗ |
| Aug 28, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 326,700 | $23.04 | $7.5M Sale | Form 4 ↗ |
| Aug 26, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 18,000 | $24.28 | $437.0K Sale | Form 4 ↗ |
| Aug 26, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 18,000 | $24.28 | $437.0K Sale | Form 4 ↗ |
| Aug 26, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 18,000 | $24.28 | $437.0K Sale | Form 4 ↗ |
| Aug 25, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 16,300 | $24.74 | $403.3K Sale | Form 4 ↗ |
| Aug 25, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 16,300 | $24.74 | $403.3K Sale | Form 4 ↗ |
| Aug 25, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 16,300 | $24.74 | $403.3K Sale | Form 4 ↗ |
| Aug 24, 2026 | David R. Pelizzon Director, 10% owner | KIDS OrthoPediatrics Corp. | Sale | 4,000 | $25.75 | $103.0K Sale | Form 4 ↗ |
| Aug 24, 2026 | Jennifer N. Pritzker 10% owner | KIDS OrthoPediatrics Corp. | Sale | 4,000 | $25.75 | $103.0K Sale | Form 4 ↗ |
| Aug 24, 2026 | Squadron Capital Holdings LLC 10% owner | KIDS OrthoPediatrics Corp. | Sale | 4,000 | $25.75 | $103.0K Sale | Form 4 ↗ |
| Mar 16, 2026 | Joseph W. Hauser Pres. Trauma & Def. Correction | KIDS OrthoPediatrics Corp. | Sale | 8,596 | $17.25 | $148.3K Sale | Form 4 ↗ |
| Mar 16, 2026 | Fred Hite COO and CFO, Director | KIDS OrthoPediatrics Corp. | Sale | 12,993 | $17.25 | $224.1K Sale | Form 4 ↗ |
| Mar 16, 2026 | David R. Bailey President and CEO, Director | KIDS OrthoPediatrics Corp. | Sale | 19,535 | $17.25 | $337.0K Sale | Form 4 ↗ |
| Mar 16, 2026 | Gregory A. Odle President of Scoliosis | KIDS OrthoPediatrics Corp. | Sale | 8,433 | $17.25 | $145.5K Sale | Form 4 ↗ |
| Mar 16, 2026 | Daniel J. Gerritzen General Counsel and Secretary | KIDS OrthoPediatrics Corp. | Sale | 8,614 | $17.25 | $148.6K Sale | Form 4 ↗ |
| Aug 21, 2025 | Fred Hite COO and CFO, Director | KIDS OrthoPediatrics Corp. | Buy | 5,076 | $19.41 | $98.5K Buy | Form 4 ↗ |
| Mar 18, 2025 | Daniel J. Gerritzen General Counsel and Secretary | KIDS OrthoPediatrics Corp. | Sale | 5,310 | $24.86 | $132.0K Sale | Form 4 ↗ |
| Mar 18, 2025 | David R. Bailey President and CEO, Director | KIDS OrthoPediatrics Corp. | Sale | 6,620 | $24.86 | $164.6K Sale | Form 4 ↗ |
| Mar 18, 2025 | Fred Hite COO and CFO, Director | KIDS OrthoPediatrics Corp. | Sale | 6,443 | $24.86 | $160.2K Sale | Form 4 ↗ |
| Mar 18, 2025 | Gregory A. Odle President of Scoliosis | KIDS OrthoPediatrics Corp. | Sale | 5,359 | $24.86 | $133.2K Sale | Form 4 ↗ |
| Mar 18, 2025 | Joseph W. Hauser Pres. Trauma & Def. Correction | KIDS OrthoPediatrics Corp. | Sale | 5,300 | $24.86 | $131.8K Sale | Form 4 ↗ |
32 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:02 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances